
Grapiprant
CAS No. 415903-37-6
Grapiprant( CJ-023423 | AAT-007 )
Catalog No. M14424 CAS No. 415903-37-6
A novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 40 | Get Quote |
![]() ![]() |
5MG | 65 | Get Quote |
![]() ![]() |
10MG | 110 | Get Quote |
![]() ![]() |
25MG | 177 | Get Quote |
![]() ![]() |
50MG | 335 | Get Quote |
![]() ![]() |
100MG | 506 | Get Quote |
![]() ![]() |
200MG | 764 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGrapiprant
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation.
-
DescriptionA novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation associated with osteoarthritis (OA) in dogs.Pain Phase 2 Clinical(In Vivo):Grapiprant (0-50 mg/kg; oral administration; every 24 hours; for 9 months; beagles) is safe for dogs by long-term oral administration. Efficacy of Grapiprant in the treatment of dogs with osteoarthritis needs to be evaluated in other studies.
-
In Vitro——
-
In VivoGrapiprant (0-50 mg/kg; oral administration; every 24 hours; for 9 months; beagles) is safe for dogs by long-term oral administration. Efficacy of Grapiprant in the treatment of dogs with osteoarthritis needs to be evaluated in other studies . Animal Model:36 beagles of both sexes (9-month-old) Dosage:0 mg/kg, 1 mg/kg, 6 mg/kg, or 50 mg/kg Administration:Oral administration; every 24 hours; for 9 months Result:Long-term oral administration was safe for dogs.
-
SynonymsCJ-023423 | AAT-007
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorProstaglandin Receptor
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number415903-37-6
-
Formula Weight491.6052
-
Molecular FormulaC26H29N5O3S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NCCC1=CC=C(C=C1)N2C(CC)=NC3=C(N=C(C=C32)C)C)NS(C4=CC=C(C=C4)C)(=O)=O
-
Chemical NameBenzenesulfonamide, N-[[[2-[4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rausch-Derra LC, et al. Am J Vet Res. 2015 Oct;76(10):853-9.
2. Rausch-Derra LC, et al. J Vet Pharmacol Ther. 2016 Dec;39(6):566-571.
3. De Vito V, et al. J Pharm Biomed Anal. 2016 Jan 25;118:251-8.
molnova catalog



related products
-
Omidenepag
Omidenepag (UR-7276) is a selective and potent prostaglandin E2 receptor 2 (EP2) agonist and a novel topical ocular hypotensive agent.Omidenepag is used in the study of glaucoma and hypertension.
-
Terutroban
Terutroban (S-18886) is a potent, selective antagonist of the thromboxane receptor (Prostanoid TP receptor) that blocks thromboxane induced platelet aggregation and vasoconstriction.
-
Methyl 4-hydroxycinn...
Methyl p-coumarate (Methyl 4-hydroxycinnamate), an orally active esterified derivative of p-Coumaric acid (pCA), can be isolated from the flower of?Trixis michuacana?var?longifolia.